🇦🇺 +61 2 9976 2467 🇨🇦 1-833 4 Cannim Mon-Fri : 09:00 - 17:00


The Endocannabinoid System as an Emerging Target of Pharmacotherapy

It is safe to predict that new therapeutic agents that affect the activity of the endocannaboinoid system will emerge and become members of...

Getting High on the Endocannabinoid System

by Bradley E. Alger, Ph.D. The endogenous cannabinoid system—named for the plant that led to its discovery—is one of the most important physiologic...

Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study

Current levels and dangers of opioid use in the U.S. warrant the investigation of harm-reducing treatment alternatives.

Prescribing cannabis for harm reduction

Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for...

Research Shows CBD Benefits 50+ Conditions

Over the last few years, Cannabidiol (CBD) has exploded into the world of health and wellness.

The Endocannabinoid System, Cannabinoids and Pain (Oct 2013)

The endocannabinoid system is involved in a host of homeostatic and physiologic functions, including modulation of pain and inflammation.

Pain – randomised controlled trials and other studies – bibliography

Access the list here: https://www.tga.gov.au/pain-randomised-controlled-trials-and-other-studies

Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting

by Mary Barna Bridgeman, PharmD, BCPS, BCGP and Daniel T. Abazia, PharmD, BCPS, CPE The purpose of this article is to review the historical...

Re-branding cannabis: the next generation of chronic pain medicine? (Dec 2014)

by Gregory T Carter, Simone P Javaher, Michael HV Nguyen, Sharon Garret & Beatriz H Carlini The field of pain medicine is at...
1 2 3